[Phyto Chem (India) Limited](phyto chem) reported a widened net loss of ₹180.28 lakh for the financial year ended March 31, 2026, compared to a net loss of ₹99.15 lakh in the previous year, as revenue from operations declined 35.6% to ₹907.05 lakh. The company's Board of Directors approved the audited financial results for the fourth quarter and fiscal year during a meeting held on May 29, 2026. The statutory auditors, M/s. Yelamanchi & Associates, issued an unmodified opinion on the results, confirming compliance with Indian Accounting Standards (Ind AS) and SEBI regulations.

Financial Performance

The decline in financial performance was driven by a sharp drop in revenue, which fell from ₹1407.84 lakh in FY25 to ₹907.05 lakh in FY26. For the fourth quarter ended March 31, 2026, the company reported a net loss of ₹27.63 lakh on revenue of ₹23.16 lakh. Total income for the year decreased to ₹1090.25 lakh from ₹1655.11 lakh in the prior year. The company operates primarily in the manufacturing and marketing of pesticide formulations.

Legal and Business Updates

Apart from the financial results, the Board noted the filing of a claim application before the Interim Resolution Professional (IRP) appointed by the National Company Law Tribunal (NCLT). The claim of ₹6,21,84,043.42 has been submitted against M/s. Siri Smelters & Energy Private Limited, identified as a corporate debtor, under the Insolvency and Bankruptcy Code proceedings. The company filed the claim as an operational creditor on May 25, 2026, and the admission or reconciliation process is currently underway.

Asset and Liability Position

The company's balance sheet size contracted marginally, with total assets standing at ₹2805.29 lakh as of March 31, 2026, compared to ₹2788.66 lakh a year earlier. Current liabilities increased to ₹2278.98 lakh from ₹1982.59 lakh, primarily due to higher borrowings and trade payables. Cash and cash equivalents decreased to ₹2.37 lakh from ₹4.61 lakh in the previous year.

phyto chem has scheduled a meeting of its Board of Directors for Friday, May 29, 2026, to consider and approve the audited financial results for the fourth quarter and the financial year ended March 31, 2026. The meeting will be held at 3:30 P.M. at the company's corporate office located in Hyderabad, Telangana.

The agenda for the meeting primarily focuses on the review and approval of the financial performance for the specified period under Regulation 29 of the SEBI (LODR) Regulations, 2015. This intimation was formally communicated to the stock exchanges on May 22, 2026.

Trading Window Closure

In compliance with the Company's Code of Conduct for the Prohibition of Insider Trading, the trading window for dealing in the securities of the company has been closed for all Directors, Officers, and Designated Employees. The closure became effective from April 1, 2026.

The window will remain closed until 48 hours after the declaration and intimation of the financial results to the Stock Exchange on May 29, 2026. This measure is intended to ensure adherence to regulatory standards regarding insider trading during the period of financial announcement.

Meeting Details

The following table outlines the key details regarding the upcoming board meeting:

The communication regarding the trading window closure has already been circulated to all relevant personnel within the organization.